Research Papers
This database includes peer-reviewed publications authored by TB Alliance staff. Use the tags on the left to filter by subject, or search for a particular author or term using the search bar.
Tag: Pretomanid/PA-824
Displaying 48 papers
Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer
Publication: Molecular Pharmaceutics
5/2023
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model
Publication: Antimicrobial Agents and Chemotherapy
3/2023
Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis
Publication: PLOS Global Public Health
11/2022
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
Publication: New England Journal of Medicine
9/2022
Assessment of the Carcinogenic Potential of Pretomanid in Transgenic Tg.rasH2 Mice
Publication: International Journal of Toxicity
7/2022
Toxicity and toxicokinetic assessment of an anti-tubercular drug pretomanid in cynomolgus monkeys
Publication: Toxicology Reports
4/2022
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid
Publication: Antimicrobial Chemotherapy
3/2022
Pretomanid with Bedaquiline and Linezolid for Drug Resistant TB: A Comparison of Prospective Cohorts
4/2021
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
Publication: International Journal of Tuberculosis and Lung Disease
3/2021
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Publication: The New England Journal of Medicine
3/2020
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial
Publication: The Lancet Respiratory Medicine
11/2019
Population Pharmacokinetics of the Antituberculosis Agent Pretomanid
Publication: Antimicrobial Agents and Chemotheraphy
8/2019
Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis
Publication: Antimicrobial Agents and Chemotheraphy
7/2019
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis
Publication: Antimicrobial Agents and Chemotheraphy
4/2019